Skip to main content
Article thumbnail
Location of Repository

Breast tumour angiogenesis

By Stephen B Fox, Daniele Generali and Adrian L. Harris


The central importance of tumour neovascularization has been emphasized by clinical trials using antiangiogenic therapy in breast cancer. This review gives a background to breast tumour neovascularization in in situ and invasive breast cancer, outlines the mechanisms by which this is achieved and discusses the influence of the microenvironment, focusing on hypoxia. The regulation of angiogenesis and the antivascular agents that are used in an antiangiogenic dosing schedule, both novel and conventional, are also summarize

Topics: Angiogenesis Inhibitors, Angiogenic Proteins, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Bevacizumab, Biomarkers, Tumor, Breast Neoplasms, Cell Hypoxia, Female, Humans, Neovascularization, Pathologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor A, Cancer Research, Oncology, Medicine (all)
Year: 2007
DOI identifier: 10.1186/bcr1796
OAI identifier:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://breast-cancer-research.... (external link)
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.